Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$7.89 - $10.64 $1.42 Million - $1.92 Million
-180,000 Reduced 15.25%
1,000,000 $10.4 Million
Q1 2023

May 15, 2023

BUY
$7.07 - $17.95 $3.39 Million - $8.62 Million
480,000 Added 68.57%
1,180,000 $9.55 Million
Q3 2022

Nov 14, 2022

BUY
$13.07 - $18.22 $980,250 - $1.37 Million
75,000 Added 12.0%
700,000 $11 Million
Q2 2022

Aug 15, 2022

BUY
$10.16 - $17.08 $2.03 Million - $3.42 Million
200,000 Added 47.06%
625,000 $8.73 Million
Q1 2022

May 16, 2022

SELL
$9.74 - $17.92 $4.63 Million - $8.51 Million
-474,997 Reduced 52.78%
425,000 $7.33 Million
Q4 2021

Feb 14, 2022

SELL
$12.27 - $18.49 $2.15 Million - $3.24 Million
-175,369 Reduced 16.31%
899,997 $13.1 Million
Q3 2021

Nov 15, 2021

SELL
$13.38 - $18.8 $12.4 Million - $17.4 Million
-924,634 Reduced 46.23%
1,075,366 $19.4 Million
Q2 2021

Aug 16, 2021

SELL
$17.08 - $29.6 $20.5 Million - $35.5 Million
-1,200,000 Reduced 37.5%
2,000,000 $35.1 Million
Q1 2021

May 17, 2021

BUY
$5.86 - $27.73 $5.57 Million - $26.3 Million
950,000 Added 42.22%
3,200,000 $80.6 Million
Q4 2020

Feb 16, 2021

SELL
$2.65 - $7.61 $662,500 - $1.9 Million
-250,000 Reduced 10.0%
2,250,000 $14.6 Million
Q2 2020

Aug 14, 2020

BUY
$1.04 - $1.73 $520,000 - $865,000
500,000 Added 25.0%
2,500,000 $4.05 Million
Q1 2020

May 15, 2020

BUY
$0.75 - $2.18 $975,000 - $2.83 Million
1,300,000 Added 185.71%
2,000,000 $2.08 Million
Q2 2019

Aug 14, 2019

BUY
$2.13 - $7.06 $1.49 Million - $4.94 Million
700,000 New
700,000 $1.53 Million

Others Institutions Holding ACRS

About Aclaris Therapeutics, Inc.


  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $139M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Adage Capital Partners Gp, L.L.C. Portfolio

Follow Adage Capital Partners Gp, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.